期刊
JOURNAL OF HEPATOLOGY
卷 78, 期 2, 页码 401-414出版社
ELSEVIER
DOI: 10.1016/j.jhep.2022.09.001
关键词
Chronic liver disease; hepatocellular differentiation; transcription factors; mRNA splicing factors; transcriptional reprogramming; molecular therapies
The identity of adult hepatocytes is established during embryonic development and regulated after birth. Transcription factors and pre-mRNA splicing regulators play a crucial role in defining the transcriptome, which determines the complex functions of the liver. Persistent downregulation of key identity genes is a major factor in chronic liver disease and organ dysfunction. Therefore, understanding the disruption of core transcription factors and splicing regulators in diseased hepatocytes is clinically important.
Adult hepatocyte identity is constructed throughout embryonic development and fine-tuned after birth. A multinodular network of transcription factors, along with pre-mRNA splicing regulators, define the transcriptome, which encodes the proteins needed to perform the complex metabolic and secretory functions of the mature liver. Transient hepatocellular dedifferentiation can occur as part of the regenerative mechanisms triggered in response to acute liver injury. However, persistent downregulation of key identity genes is now accepted as a strong determinant of organ dysfunction in chronic liver disease, a major global health burden. Therefore, the identification of core transcription factors and splicing regulators that preserve hepatocellular phenotype, and a thorough understanding of how these networks become disrupted in diseased hepatocytes, is of high clinical relevance. In this context, we review the key players in liver differentiation and discuss in detail critical factors, such as HNF4a, whose impairment mediates the breakdown of liver function. Moreover, we present compelling experimental evidence demonstrating that restoration of core transcription factor expression in a chronically injured liver can reset hepatocellular identity, improve function and ameliorate structural abnormalities. The possibility of correcting the phenotype of severely damaged and malfunctional livers may reveal new therapeutic opportunities for individuals with cirrhosis and advanced liver disease. (c) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据